NCT05669547 - Dual Hormone Closed Loop in Type 1 Diabetes | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

October 3, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

January 1, 2026

Conditions

Diabetes Mellitus, Type 1Diabetes type1Diabetes

Interventions

DEVICE

dual hormone fully closed loop (DHFCL)

dual hormone fully closed loop consisting of an algorithm, sensors and both insulin and glucagon infusion.

Trial Locations (14)

Meander MC, Amersfoort

Amsterdam UMC, AMC, Amsterdam

Amsterdam UMC, VUmc, Amsterdam

OLVG, Amsterdam

Gelre Ziekenhuis, Apeldoorn

Rijnstate, Arnhem

Catharina Ziekenhuis, Eindhoven

Martini Ziekenhuis, Groningen

UMC Groningen, Groningen

Tergooi Ziekenhuis, Hilversum

LUMC, Leiden

St. Antonius, Nieuwegein

UMC Utrecht, Utrecht

Isala Klinieken, Zwolle